0001209191-11-044646.txt : 20110817
0001209191-11-044646.hdr.sgml : 20110817
20110817162923
ACCESSION NUMBER: 0001209191-11-044646
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110816
FILED AS OF DATE: 20110817
DATE AS OF CHANGE: 20110817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Peter
CENTRAL INDEX KEY: 0001495401
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-13789
FILM NUMBER: 111042806
MAIL ADDRESS:
STREET 1: 1 KENDALL SQUARE
STREET 2: B7102
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marina Biotech, Inc.
CENTRAL INDEX KEY: 0000737207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112658569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3830 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4259083600
MAIL ADDRESS:
STREET 1: 3830 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: MDRNA, Inc.
DATE OF NAME CHANGE: 20080610
FORMER COMPANY:
FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-08-16
0
0000737207
Marina Biotech, Inc.
MRNA
0001495401
Parker Peter
3830 MONTE VILLA PARKWAY
BOTHELL
WA
98021
1
0
0
0
Marina Biotech, Inc. Common Stock
2011-08-16
4
J
0
40200
0.2389
D
84010
D
As reported on a Form 4 filed on February 15, 2011, on February 11, 2011, certain stockholders of Marina Biotech, Inc. ("Marina") entered into a Transfer and Sale Agreement with Marina and the Reporting Person pursuant to which they agreed to transfer a total of 116,253 shares of Marina Common Stock that they had received as merger consideration in connection with the merger of Cequent Pharmacueticals, Inc. ("Cequent") with and into Marina to the reporting person as consideration for services rendered by the Reporting person to Cequent. On August 15, 2011, pursuant to the Transfer and Sale Agreement, the shares were transferred to the Reporting Person and on August 16, 2011, 40,200 shares were sold to cover the Reporting Person's tax obligations, which sale is reported on this Form 4.
/s/Peter S. Garcia
Attorney in Fact
2011-08-17